Holen Sie sich die Stockscreener-App
1.79
5.29%
0.09
Schlusskurs vom Vortag:
$1.70
Offen:
$1.72
24-Stunden-Volumen:
690.66K
Relative Volume:
0.52
Marktkapitalisierung:
$123.81M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-77.22M
KGV:
-1.0209
EPS:
-1.7533
Netto-Cashflow:
$-77.27M
1W Leistung:
+18.54%
1M Leistung:
+21.77%
6M Leistung:
-65.58%
1J Leistung:
+21.77%
1-Tages-Spanne:
$1.72
$1.81
1-Wochen-Bereich:
$1.47
$1.81
52-Wochen-Spanne:
$1.01
$7.80
Pepgen Inc Stock (PEPG) Company Profile
Firmenname
Pepgen Inc
Sektor
Branche
Telefon
703-456-8000
Adresse
1 MARINA PARK DRIVE, SUITE 900, BOSTON
Compare PEPG vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PEPG
Pepgen Inc
|
1.79 | 123.81M | 0 | -77.22M | -77.27M | -1.7533 |
VRTX
Vertex Pharmaceuticals Inc
|
451.63 | 114.63B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
609.94 | 63.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.72 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.09 | 37.13B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
162.99 | 34.65B | 742.00K | -1.37B | -1.07B | -7.0731 |
Pepgen Inc Stock (PEPG) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-09 | Eingeleitet | Guggenheim | Buy |
| 2024-12-16 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2024-07-31 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-12-21 | Eingeleitet | H.C. Wainwright | Buy |
Pepgen Inc Aktie (PEPG) Neueste Nachrichten
PepGen Inc (PEPG) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
PepGen Inc (PEPG) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
PepGen Inc (PEPG) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
PepGen Inc (PEPG) Valuation: PE, PB & Fair Value Analysis - TradingKey
PepGen Inc (PEPG) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
PepGen Inc (PEPG) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
PepGen Inc (PEPG) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
PepGen Inc (PEPG) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
PepGen Inc (PEPG) Institutional Confidence - TradingKey
PepGen Inc. (PEPG) Q1 2026 Earnings: Narrower Loss Beats Estimates as Clinical Programs AdvanceROA Comparison - newsline.com
PEPG Initiates Coverage On Craig-Hallum -- Rating Set to Buy - GuruFocus
Craig-Hallum initiates PepGen stock coverage with buy rating - Investing.com UK
Craig-Hallum initiates PepGen stock coverage with buy rating By Investing.com - Investing.com India
Why PEPG, SGMO, PHR Are Among Top Premarket Losers Today - Stocktwits
PEPG Q1 2026 Earnings: Narrower Loss Surpasses Expectations Amid Continued R&D Progress - newsline.com
PEPG Q1 2026 Earnings: Narrower-Than-Expected Loss Despite Lack of RevenueEarnings Momentum Score - lwvtexas.org
PEPG Q1 2026 Earnings: Narrower Loss Per Share Beats Estimates as Biotech Advances PipelineEarnings Surprise Stocks - newsline.com
PEPG Q1 2026 Earnings: Narrower-than-Expected Loss Drives Stock HigherEarnings Miss Alert - newsline.com
PepGen Inc. (PEPG) Q1 2026 Earnings: Narrowed Loss Surprises Analysts, Shares Edge HigherRevenue Beat Analysis - newsline.com
PepGen Inc. (PEPG) Q1 2026 Earnings: Narrower-than-Expected Loss Drives Cautious OptimismGuidance Revision Trend - newsline.com
PepGen Inc. (PEPG) Rallies 4.23% as Biotech Stock Tests Key Resistance at $1.55Bollinger Expansion - newsline.com
PepGen showcases research advancements on DM1 at industry conference - Traders Union
PepGen attends ANN and AOMC Congress in Perth to engage neuromuscular research community - Traders Union
PepGen's cash reserves offer comfort for now, but rising cash burn and no revenue spark concerns. Investors are urged to remain cautious due to funding needs and dilution risk. - Moomoo
PepGen (PEPG) upgraded to buy: Here's what you should know - MSN
PepGen Inc. (PEPG): Stock Holds Steady at $1.50 as Key Resistance LoomsNAAIM Exposure - newsline.com
PepGen Inc. (PEPG) Nears Support as Stock Slips SlightlyEarnings Sentiment - The Legal Advocate
PepGen Inc. (PEPG) Slips to $1.5 as Stock Navigates Key Support ZoneBPI Bear Correction - The Legal Advocate
PEPG Q1 2026 Earnings: Narrower-than-Expected Loss Signals Progress in Neuromuscular PipelineCost Structure Review - The Legal Advocate
PepGen (NASDAQ: PEPG) CTO executes mandatory sell-to-cover RSU shares - Stock Titan
PepGen Inc. (PEPG) Slips 1.95% as Stock Tests Key Support LevelsSign of Weakness - Newser
PepGen launches outreach campaign with DM1 stakeholders in Canada - Traders Union
[EFFECT] PepGen Inc. SEC Filing - Stock Titan
PEPG Q1 2026 Earnings: Narrower-Than-Expected Loss Highlights Cost DisciplineEarnings Risk Report - newsline.com
PepGen Announces Presentations at the 15th International Myotonic Dystrophy Consortium Highlighting Clinical Data from the PGN-EDODM1 Program - BioSpace
PepGen’s PGN-EDODM1 Shows Promising Safety and Efficacy in Myotonic Dystrophy Type 1 Clinical Trials – FREEDOM2 Study Update - Minichart
H.C. Wainwright reiterates PepGen stock rating on data outlook By Investing.com - Investing.com South Africa
PepGen Announces Presentations at the 15th International Myotonic Dystrophy Consortium Highlighting - PharmiWeb.com
PepGen unveils new PGN-EDODM1 clinical data at IDMC-15 - Traders Union
PepGen Highlights DM1 Program Progress in Updated Presentation - TipRanks
H.C. Wainwright reiterates PepGen stock rating on data outlook - Investing.com
PepGen updates corporate presentation, highlights FREEDOM2 milestones and PGN-EDODM1 data - TradingView
PepGen (NASDAQ: PEPG) details DM1 trial data and cash runway outlook - Stock Titan
Analysts Offer Insights on Healthcare Companies: PepGen Inc. (PEPG) and Protara Therapeutics (TARA) - The Globe and Mail
PepGen (PEPG) loses 14.3% in 4 weeks, here's why a trend reversal may be around the corner - MSN
PepGen (PEPG) Loses 14.3% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance UK
PepGen files to offer up to $400 mln in securities from time to time - marketscreener.com
PepGen Files To Offer Up To $400 Mln In Securities From Time To Time - TradingView
According to documents submitted to the SEC, biotechnology company PepGen Inc. has signed a new sales agreement, which will completely replace the company's previous sales arrangement. - Bitget
PepGen Files $400 Million Mixed Shelf - Moomoo
PepGen (NASDAQ: PEPG) ups capital flexibility with $400M shelf and $100M ATM - Stock Titan
Finanzdaten der Pepgen Inc-Aktie (PEPG)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.74%
1.44%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):